Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD):
Efrosini Dima1, Anna Kyriakoudi1, Maria Kaponi1
11th Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens and "Sotiria" Chest Disease Hospital, 11527, Athens, Greece.
Chronic obstructive pulmonary disease (COPD) involves immune dysregulation and bacterial infections. The lung microbiome
Area of Science:
- Pulmonary Medicine
- Microbiology
- Immunology
Background:
- Chronic obstructive pulmonary disease (COPD) is a complex inflammatory lung condition.
- While smoking is a primary cause, infections and immune dysregulation are critical in COPD progression.
- The lung microbiome's role in COPD pathogenesis is increasingly recognized.
Purpose of the Study:
- To explore the intricate relationship between the lung microbiome and COPD.
- To understand how bacterial ecology influences host immunity and disease phenotype in COPD patients.
- To highlight the clinical relevance and remaining questions regarding the COPD microbiome.
Main Methods:
- Utilizing culture-independent techniques to analyze lung microbiota composition.
- Investigating the impact of COPD severity, exacerbations, and treatments on lung microbiota.
- Examining the interplay between specific bacterial taxa and host immune responses.
Main Results:
- COPD is associated with dysregulated immunity and altered bacterial colonization.
- Lung microbiome composition is influenced by COPD severity, exacerbations, and treatments.
- Specific bacterial taxa may modulate host immune responses and affect COPD phenotypes.
Conclusions:
- The lung microbiome plays a significant role in COPD development and progression.
- Understanding the COPD microbiome offers potential for novel therapeutic strategies.
- Further research is needed to fully elucidate the clinical implications of the lung microbiome in COPD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

